943 related articles for article (PubMed ID: 31373203)
1. Identification via a Parallel Hit Progression Strategy of Improved Small Molecule Inhibitors of the Malaria Purine Uptake Transporter that Inhibit
Sosa Y; Deniskin R; Frame IJ; Steiginga MS; Bandyopadhyay D; Graybill TL; Kallal LA; Ouellette MT; Pope AJ; Widdowson KL; Young RJ; Akabas MH
ACS Infect Dis; 2019 Oct; 5(10):1738-1753. PubMed ID: 31373203
[TBL] [Abstract][Full Text] [Related]
2. Yeast-based high-throughput screen identifies Plasmodium falciparum equilibrative nucleoside transporter 1 inhibitors that kill malaria parasites.
Frame IJ; Deniskin R; Rinderspacher A; Katz F; Deng SX; Moir RD; Adjalley SH; Coburn-Flynn O; Fidock DA; Willis IM; Landry DW; Akabas MH
ACS Chem Biol; 2015 Mar; 10(3):775-83. PubMed ID: 25602169
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
4. Impact of Field Isolate Identified Nonsynonymous Single Nucleotide Polymorphisms on
Sosa Y; Egbo D; Akabas MH
ACS Infect Dis; 2020 Feb; 6(2):205-214. PubMed ID: 31876139
[No Abstract] [Full Text] [Related]
5. Purine import into malaria parasites as a target for antimalarial drug development.
Frame IJ; Deniskin R; Arora A; Akabas MH
Ann N Y Acad Sci; 2015 Apr; 1342(1):19-28. PubMed ID: 25424653
[TBL] [Abstract][Full Text] [Related]
6. Transport of purines and purine salvage pathway inhibitors by the Plasmodium falciparum equilibrative nucleoside transporter PfENT1.
Riegelhaupt PM; Cassera MB; Fröhlich RF; Hazleton KZ; Hefter JJ; Schramm VL; Akabas MH
Mol Biochem Parasitol; 2010 Jan; 169(1):40-9. PubMed ID: 19818813
[TBL] [Abstract][Full Text] [Related]
7. Accessibility of substituted cysteines in TM2 and TM10 transmembrane segments in the
Nishtala SN; Arora A; Reyes J; Akabas MH
J Biol Chem; 2019 Feb; 294(6):1924-1935. PubMed ID: 30541922
[TBL] [Abstract][Full Text] [Related]
8. Putative purine nucleoside interacting residues in the malaria parasite purine uptake transporter PfENT1 are critical for transporter function.
Dillague C; Akabas MH
PLoS One; 2023; 18(12):e0293923. PubMed ID: 38113238
[TBL] [Abstract][Full Text] [Related]
9. Substrate and Inhibitor Specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1.
Arora A; Deniskin R; Sosa Y; Nishtala SN; Henrich PP; Kumar TR; Fidock DA; Akabas MH
Mol Pharmacol; 2016 Jun; 89(6):678-85. PubMed ID: 27048953
[TBL] [Abstract][Full Text] [Related]
10. Transport of nucleosides across the Plasmodium falciparum parasite plasma membrane has characteristics of PfENT1.
Downie MJ; Saliba KJ; Howitt SM; Bröer S; Kirk K
Mol Microbiol; 2006 May; 60(3):738-48. PubMed ID: 16629674
[TBL] [Abstract][Full Text] [Related]
11. A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose Transporters.
Kraft TE; Heitmeier MR; Putanko M; Edwards RL; Ilagan MX; Payne MA; Autry JM; Thomas DD; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2016 Dec; 60(12):7407-7414. PubMed ID: 27736766
[TBL] [Abstract][Full Text] [Related]
12. Uptake of purines in Plasmodium falciparum-infected human erythrocytes is mostly mediated by the human equilibrative nucleoside transporter and the human facilitative nucleobase transporter.
Quashie NB; Ranford-Cartwright LC; de Koning HP
Malar J; 2010 Jan; 9():36. PubMed ID: 20113503
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Dual-Stage Malaria Inhibitors with New Targets.
Raphemot R; Lafuente-Monasterio MJ; Gamo-Benito FJ; Clardy J; Derbyshire ER
Antimicrob Agents Chemother; 2015 Dec; 60(3):1430-7. PubMed ID: 26666931
[TBL] [Abstract][Full Text] [Related]
14. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
[TBL] [Abstract][Full Text] [Related]
15. Thousands of chemical starting points for antimalarial lead identification.
Gamo FJ; Sanz LM; Vidal J; de Cozar C; Alvarez E; Lavandera JL; Vanderwall DE; Green DV; Kumar V; Hasan S; Brown JR; Peishoff CE; Cardon LR; Garcia-Bustos JF
Nature; 2010 May; 465(7296):305-10. PubMed ID: 20485427
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of the substrate recognition and inhibition mechanism of Plasmodium falciparum nucleoside transporter PfENT1.
Wang C; Yu L; Zhang J; Zhou Y; Sun B; Xiao Q; Zhang M; Liu H; Li J; Li J; Luo Y; Xu J; Lian Z; Lin J; Wang X; Zhang P; Guo L; Ren R; Deng D
Nat Commun; 2023 Mar; 14(1):1727. PubMed ID: 36977719
[TBL] [Abstract][Full Text] [Related]
17. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
18. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
[TBL] [Abstract][Full Text] [Related]
19.
Santos BMD; Gonzaga DTG; da Silva FC; Ferreira VF; Garcia CRS
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824696
[TBL] [Abstract][Full Text] [Related]
20. Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol on Plasmodium falciparum.
Ahiya AI; Bhatnagar S; Morrisey JM; Beck JR; Vaidya AB
Microbiol Spectr; 2022 Feb; 10(1):e0015822. PubMed ID: 35196803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
